Yegin, ZeynepYildirim, Seval Cing2025-03-232025-03-2320242791-9935https://hdl.handle.net/11486/2314Colorectal cancer prevalence has rapidly increased due to dietary changes to Western style. The regulation of the gut microbiota may serve as a promising approach in colorectal cancer management. The dysbiosis of the gut microbiome affects cancer development because of its roles in inflammation and genotoxicity. Cell culture studies, animal studies, and some novel clinical studies refer to the therapeutic potential of Bifidobacterium.Bati tarzi beslenme degisiklikleri nedeniyle kolorektal kanser prevalansi hizla artis göstermistir. Bagirsak mikrobiyotasinin düzenlenmesi kolorektal kanser tedavisinde ümit verici bir yaklasim olarak hizmet edebilir. Bagirsak mikrobiyomunun disbiyozu, inflamasyon ve genotoksisitedeki rollerinden dolayi kanser gelisimini etkilemektedir. Hücre kültürü çalismalari, hayvan çalismalari ve bazi yeni klinik çalismalar Bifidobakterinin terapötik potansiyeline isaret etmektedir.eninfo:eu-repo/semantics/openAccessBifidobacteriumcolorectal cancerapoptosisprobioticsOther4315616010.58961/hmj.1508458https://doi.org/10.58961/hmj.1508458